Quo Vadis Advanced Prostate Cancer Therapy? Novel Treatment Perspectives and Possible Future Directions

Molecules. 2021 Apr 12;26(8):2228. doi: 10.3390/molecules26082228.

Abstract

Prostate cancer is a very common disease, which is, unfortunately, often the cause of many male deaths. This is underlined by the fact that the early stages of prostate cancer are often asymptomatic. Therefore, the disease is usually detected and diagnosed at late advanced or even metastasized stages, which are already difficult to treat. Hence, it is important to pursue research and development not only in terms of novel diagnostic methods but also of therapeutic ones, as well as to increase the effectiveness of the treatment by combinational medicinal approach. Therefore, in this review article, we focus on recent approaches and novel potential tools for the treatment of advanced prostate cancer; these include not only androgen deprivation therapy, antiandrogen therapy, photodynamic therapy, photothermal therapy, immunotherapy, multimodal therapy, but also poly(ADP-ribose) polymerase, Akt and cyclin-dependent kinase inhibitors.

Keywords: advanced prostate cancer treatment; androgen deprivation therapy; antiandrogen therapy; cancer diagnostics; immunotherapy; multimodal therapy; photodynamic therapy; phototherapy; specific drug targeting.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents, Hormonal / chemistry
  • Antineoplastic Agents, Hormonal / pharmacology
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Humans
  • Immunotherapy
  • Male
  • Phototherapy
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / immunology
  • Prostatic Neoplasms / therapy*

Substances

  • Antineoplastic Agents, Hormonal